Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31-Reference-Cited by-同舟云学术

Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31

Published:2018-07-26 Issue:18 Volume:7 Page:1800341
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Chen Naihan¹^ORCID,Kroger Charles J.²,Tisch Roland M.²,Bachelder Eric M.¹,Ainslie Kristy M.¹

Affiliation:

1. Division of Pharmacoengineering and Molecular Pharmaceutics; Eshelman School of Pharmacy; The University of North Carolina at Chapel Hill; Chapel Hill NC 27599 USA

2. Department of Microbiology and Immunology; School of Medicine; The University of North Carolina at Chapel Hill; Chapel Hill NC 27599 USA

Funder

Juvenile Diabetes Research Foundation

University of North Carolina at Chapel Hill

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

North Carolina Biotech Center Institutional

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/adhm.201800341/fullpdf

Reference51 articles.

1. Metabolomics in diabetic complications

2. Inducing immune tolerance: a focus on Type 1 diabetes mellitus

3. Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes

4. A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

5. Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen-specific T cell responses in autoimmune diabetes;Frontiers in Immunology;2024-08-15

2. Designing biomaterials for the treatment of autoimmune diseases;Applied Materials Today;2024-08

3. Administration of ROS-Scavenging Cerium Oxide Nanoparticles Simply Mixed with Autoantigenic Peptides Induce Antigen-Specific Immune Tolerance against Autoimmune Encephalomyelitis;ACS Applied Materials & Interfaces;2024-06-21

4. Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives;Acta Pharmaceutica Sinica B;2024-05

5. Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine;International Journal of Pharmaceutics;2024-03